Advantage Solutions Stock (NASDAQ: ADVWW)

Latest news for Advantage Solutions (NASDAQ:ADVWW) Stock

Advantage Solutions Inc is the provider of outsourced sales and marketing solutions to consumer goods companies and retailers. It has a technology-enabled platform of sales and marketing services like headquarter sales, retail merchandising, in-store sampling, digital commerce, and shopper marketing. For brands and retailers of all sizes, the firm helps to get the right products on the shelf and into the hands of consumers. The company helps its clients to sell more while spending less. Advantage has offices throughout North America and strategic investments in select markets throughout Africa, Asia, Australia, and Europe through which it services the global needs of multinational, regional, and local manufacturers. Its services are provided across two segments sales and marketing.

Advantage Solutions Inc

Barclays analyst Lauren Lieberman maintains Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Overweight and raises the price target from $295 to $309.

News

Price Target

Analyst Ratings

Barclays Maintains Overweight on Constellation Brands, Raises Price Target to $309

Barclays analyst Andrew Lazar maintains Hershey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) with a Equal-Weight and lowers the price target from $204 to $202.

Barclays Maintains Equal-Weight on Hershey, Lowers Price Target to $202

Options

Markets

Trading Ideas

PYPL

PayPal Oct 18 $80 Calls Sweep (45) Near The Ask: 2399 @ $1.701 Vs 9346 OI; Earnings 10/30 After Close [est] Ref=$78.525

<ul>
<li>Omicron KP.2 variant adapted vaccine COMIRNATY is now authorized in Canada for individuals 6 months of age and older. It is expected to be available in Canada in the coming weeks.</li>
<li>The updated COVID-19 vaccine is tailored to the KP.2 strain of the SARS-CoV-2 Omicron JN.1 lineage.</li>
</ul>
KIRKLAND, QC, Sept. 24, 2024 /CNW/ - <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4261536-1&amp;h=4008310292&amp;u=https%3A%2F%2Fwww.pfizer.ca%2Fen&amp;a=Pfizer+Canada%C2%A0ULC">Pfizer Canada&nbsp;ULC</a>&nbsp;and <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4261536-1&amp;h=3766478229&amp;u=https%3A%2F%2Fwww.biontech.com%2F&amp;a=BioNTech+SE">BioNTech SE</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>, ", BioNTech", )))) announced today that Health Canada has authorized the KP.2 variant adapted COMIRNATY&#xAE; COVID-19 vaccine for ages 6 months and older. The updated COMIRNATY&#xAE;&nbsp;vaccine targets the Omicron KP.2 variant, one of the most recently circulating SARS-CoV-2 lineages.
The adapted COVID-19 vaccine will be available in Canada as a single dose for individuals 5 years of age and older,&nbsp;regardless of prior COVID-19 vaccination history. For children 6 months through 4 years of age, COMIRNATY&#xAE; is&nbsp;authorized for administration as a three-dose series in those without a history of completion of a COVID-19 primary vaccination course, or as a single dose for those with a history of completion of a COVID-19 primary vaccination course.
The newly formulated vaccine will be available in pharmacies and vaccination centers across the country in the fall. Each province and territory will have its own pathway for accessing the vaccine, and individuals are encouraged to refer to their provincial/territorial authorities for more information.
The COVID-19 Vaccines (COMIRNATY&#xAE;) by Pfizer and BioNTech are based on BioNTech's proprietary mRNA technology and were developed by both companies. BioNTech is the Marketing Authorization Holder for COMIRNATY and its adapted vaccines in the United States, the European Union, the United Kingdom, Canada and other countries, and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries.

Biotech

Global

General

BNTX

Pfizer Canada And BioNTech Receive Health Canada Approval Of Omicron KP.2 Variant Adapted COVID-19 Vaccine

<a href="https://www.benzinga.com/personal-finance/24/08/40318568/mark-cuban-says-to-get-rich-invest-10-of-savings-in-high-risk-investments-but-if-its-bitcoin-thr">Mark Cuban</a> is on a mission, and Vice President Kamala Harris seems ready to help. Cuban posted on X (formerly Twitter) that he recently spoke with Harris&#8217; team about an issue close to his heart: protecting American businesses from Chinese knockoffs.
In his post, Cuban called knockoffs &#8220;a plague on small businesses&#8221; and explained their serious impact. &#8220;They cost them time, money and may even put them out of business,&#8221; he warned. For many small business owners, it feels like playing an endless game of whack-a-mole, where counterfeit products keep popping up.
Don't Miss:
<ul>
<li>Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.</li>
<li>General Motors and other leaders revealed to be<a href="https://www.benzinga.com/money/energyx"> investing in this revolutionary lithium start-up — allowing easy entry by launching at just $9.50/share with a $1,000 minimum.</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>
Cuban raised an interesting question in his post: "Should we require marketplace platforms to vet all foreign manufacturers selling to USA consumers?" It&#8217;s a tough nut to crack, but Cuban is looking for suggestions on the best approach.
He didn't share further details about his conversation with Harris' team or any specific strategies discussed, leaving many curious about what's next.
Counterfeiting has been a growing problem in the age of online shopping. According to the Office of the Intellectual Property Enforcement Coordinator, knockoffs cost American companies more than $200 billion annually. That's a staggering number—and it's not just about money. Over 750,000 jobs have been lost due to fake products flooding the market.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
China has been singled out as the top offender. Last year, a report from the Office of the U.S. Trade Representative showed China is the leading source of counterfeit goods seized by U.S. Customs. That fact isn't lost on Cuban, who seems ready to take action.
In his post, Cuban emphasized that <a href="https://www.benzinga.com/personal-finance/24/08/40466143/kamala-harris-joins-trump-in-pushing-for-tax-free-tips-critics-say-its-a-silly-idea-no-matter-wh">Vice President Harris</a> is also laser-focused on supporting American businesses and ensuring they're not facing unfair competition abroad. &#8220;Kamala is focused on supporting and protecting American companies from unfair foreign competition. Let me know what suggestions you have!&#8221; Cuban wrote, inviting others to join the conversation.
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: A billion-dollar investment strategy with minimums as low as $10 —<a href="https://www.benzinga.com/money/fundrise-flagship-fund"> you can become part of the next big real estate boom today.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Cuban and Harris' teams have yet to comment on the details of their conversation. But this isn't the first Cuban publicly aligned with Harris' economic plans. The &#8220;Shark Tank&#8221; star has been a vocal supporter of Harris since she took over as the Democratic nominee from President Biden, frequently praising her pro-business stance.
"I talk to them. I tell them I&#8217;m going to say what&#8217;s on my mind," Cuban revealed in an earlier interview with Axios, referring to his open discussions with Harris&#8217; team. &#8220;They say as long as you say you don&#8217;t speak for us, go for it.&#8221;
<hr class="wp-block-separator has-alpha-channel-opacity" />
Trending: Don&#8217;t miss out on the next Nvidia &#8211;<a href="https://www.benzinga.com/money/fundrise-innovation-fund"> you can invest in the future of AI for only $10.</a>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Cuban's support for Harris even extends to health care. He&#8217;s been pushing to lower drug prices through his company Mark Cuban Cost Plus Drugs, which aims to offer affordable medications online. His efforts align with Harris' previous promise to take on "pharmacy middlemen" as part of her economic agenda.
During a September interview on CNBC's &#8220;Squawk Box,&#8221; Cuban went even further, calling Harris the most pro-business leader he's ever seen. &#8220;She&#8217;s talked more about entrepreneurs and helping them have access to investment than any president I've heard,&#8221; he told host Andrew Ross Sorkin.
Read Next:
<ul>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>Unlock a $400 billion opportunity by investing in the future of EV infrastructure on<a href="https://www.benzinga.com/money/dunamis-1"> this startup already valued at $50 million with just $500</a>.</li>
</ul>

Startups

Mark Cuban Wants To Crack Down On Chinese Knockoffs – Says Vice President Kamala Harris Is On Board With His Plan

<a href="https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-takes-action-against-invitation-homes-deceiving-renters-charging-junk-fees-withholding-security" title="https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-takes-action-against-invitation-homes-deceiving-renters-charging-junk-fees-withholding-security">https://www.ftc.gov/news-events/news/press-releases/2024/09/ftc-takes-action-against-invitation-homes-deceiving-renters-charging-junk-fees-withholding-security</a>

Legal

INVH

Invitation Homes Has Agreed To A Proposed Settlement Order That Would Require The Company To Turn Over $48M To Be Used To Refund Consumers Harmed By Its Actions

Jefferies analyst Glen Santangelo maintains Pacira BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCRX#NASDAQ">PCRX</a>) with a Buy and raises the price target from $15 to $18.

PCRX

Jefferies Maintains Buy on Pacira BioSciences, Raises Price Target to $18

Jefferies analyst Joseph Gallo maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Buy and raises the price target from $315 to $330.

CYBR

Jefferies Maintains Buy on CyberArk Software, Raises Price Target to $330

To gain an edge, this is what you need to know today.
<figure class="wp-block-image size-large is-resized"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2024/09/2024-09-24_08h10_11.png" alt="" style="width:624px" /></figure>
<h3 class="wp-block-heading">AI Exuberance</h3>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-ai-exuberance-copper-oil-rise-pwr-mc-09242024">click here</a> for an enlarged chart of Quanta Services Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>).
Note the following:
<ul>
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of PWR stock is being used to illustrate the point.</li>
<li>Artificial intelligence data centers are power hungry.&nbsp; In the stock market, exuberance for stocks that help power AI data centers has reached a fever pitch.</li>
<li>The chart shows PWR stock has broken out.&nbsp; Quanta Services is a major contractor for utilities.</li>
<li>Volume on the chart shows that the volume on the breakout was higher than the recent volume, but not as high as it should have been to generate high conviction in the breakout.</li>
<li>RSI on the chart shows that PWR stock is very overbought.</li>
<li>The technical breakout is bringing in aggressive buying in PWR stock from investors who trade only on technicals.</li>
<li>The momo crowd is aggressively buying PWR stock.</li>
<li>As full disclosure, PWR stock is in The Arora Report&#8217;s ZYX Buy Core Model Portfolio.&nbsp; The Arora Report is long from $37.&nbsp;</li>
<li>From a valuation perspective, PWR stock is now expensive.&nbsp; It is trading at a trailing PE of 56 and a forward PE of 29.</li>
<li>Yesterday, we shared with readers about China:</li>
</ul>
<blockquote class="wp-block-quote is-layout-flow wp-block-quote-is-layout-flow">Central Bank Governor Pan Gongsheng will hold a conference tomorrow.
</blockquote>
<ul>
<li>China is making a big move.
<ul>
<li>People's Bank of China (PBC) is lowering its reserve requirement ratio by 50 basis points.</li>
<li>The bank has lowered its seven day repurchase rate by 20 basis points.</li>
<li>The bank may soon lower its prime rate.</li>
<li>The down payment requirement for second homes has been lowered to 15% from 25%.</li>
</ul>
</li>
<li>Chinese stocks are jumping.&nbsp; Stocks in Hong Kong jumped 4.1% and 4.2% in Shanghai.</li>
<li>Investors in the U.S. should not underestimate the impact of these moves in China. &nbsp;The moves are generating position sentiment.</li>
<li>Copper, steel, oil, and other commodities are moving up on the China moves.</li>
<li>As full disclosure, Copper stock Freeport-McMoRan Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) is in The Arora Report&#8217;s ZYX Buy Core Model Portfolio.  The Arora Report also has a short term trade on oil ETF United States Oil ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>).</li>
<li>The Conference Board's consumer confidence data will be released at 10am ET and may be market moving.</li>
</ul>
<h3 class="wp-block-heading">Magnificent Seven Money Flows</h3>
In the early trade, money flows are positive in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
In the early trade, money flows are neutral in Alphabet Inc Class C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), and NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
In the early trade, money flows are negative in Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
In the early trade, money flows are mixed in SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
<h3 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h3>
Investors can gain an edge by knowing money flows in SPY and QQQ.&nbsp; Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.&nbsp; The most popular ETF for gold is SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>).&nbsp; The most popular ETF for silver is iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>).&nbsp; The most popular ETF for oil is USO.
<h3 class="wp-block-heading">Bitcoin</h3>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is range bound.
<h3 class="wp-block-heading">Protection Band And What To Do Now</h3>
It is important for investors to look ahead and not in the rearview mirror.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h3 class="wp-block-heading">Traditional 60/40 Portfolio</h3>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Asia

Commodities

$BTC

AAPL

AMZN

GOOG

MSFT

NVDA

TSLA

Power For AI Exuberance Reaches Fever Pitch – Quanta Breaks Out; Copper And Oil Rise On Chinese Move

Intuitive Machines Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) is making waves in the stock market, skyrocketing 113% over the past year and a jaw-dropping <a href="https://www.benzinga.com/quote/LUNR/news">240% year-to-date</a>.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="631" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102314/Screenshot-2024-09-24-at-5.10.05-PM.png" alt="" class="wp-image-563384" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102314/Screenshot-2024-09-24-at-5.10.05-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102314/Screenshot-2024-09-24-at-5.10.05-PM-300x218.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092424&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Don't miss out on this unparalleled opportunity:
<ul>
<li><a href="https://www.benzinga.com/events/small-cap/global-small-cap-conference-2024/" target="_blank" rel="noreferrer noopener">Register now to secure your spot at Benzinga's Largest SmallCap Conference ever in Chicago!</a></li>
</ul>
But wait, it gets better—over just the last five days, Intuitive Machines&#8217; stock is up 38.21%. It has now made a Golden Cross &#8211; a bullish sign indicating further positive momentum for investors.
With that stride, this small cap space stock now commands a $495.21 million in market capitalization.
So, what's fueling this rocket ride?
<h2 class="wp-block-heading">A Stellar Contract: LUNR Strikes Gold With NASA</h2>
The answer lies in the company's recent announcement: Intuitive Machines has been awarded a NASA contract for communication and navigation services in the near-space region. This contract has a potential maximum value of $4.82 billion.
This firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) contract has a base period of five years, starting Oct. 1, with an option to extend another five years through 2034. It sets the stage for the debut of Intuitive Machines' lunar satellite constellation, which is crucial for NASA's Artemis campaign to create a long-term presence on the Moon.
"This contract marks an inflection point in Intuitive Machines' leadership in space communications and navigation," said CEO Steve Altemus. Partnering with NASA not only boosts the company's profile but also positions it at the forefront of the emerging lunar economy.
<h2 class="wp-block-heading">Lift-Off Alert: Golden Cross Point To A Space Surge</h2>
So, what does the chart say about Intuitive Machines&#8217; stock trajectory?
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="631" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102140/Screenshot-2024-09-24-at-5.10.25-PM.png" alt="" class="wp-image-563377" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102140/Screenshot-2024-09-24-at-5.10.25-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102140/Screenshot-2024-09-24-at-5.10.25-PM-300x218.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092424&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
With the share price soaring above its eight, 20 and 50-day simple moving averages (SMA), the trend is firmly bullish. The Golden Cross made by the 50-day SMA at $4.87, crossing over the 200-day SMA at $4.64 &#8211; has triggered a potential for upward momentum, suggesting that upward price trends may continue.
However, it&#8217;s essential to note that the stock is experiencing selling pressure, which indicates a potential risk of future bearish movement.
Read Also: <a href="https://www.benzinga.com//node/40919566">Intuitive Machines Stock Is Soaring: What&#8217;s Going On?</a>
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092424&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="631" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102459/Screenshot-2024-09-24-at-5.09.42-PM.png" alt="" class="wp-image-563389" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102459/Screenshot-2024-09-24-at-5.09.42-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24102459/Screenshot-2024-09-24-at-5.09.42-PM-300x218.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092424&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The Moving Average Convergence Divergence (MACD) indicator sits at 0.95, signaling that Intuitive Machines&#8217; stock is a bullish play. 
However, the Relative Strength Index (RSI) is at 66.07, is near overbought levels at 70. 
Meanwhile, the Bollinger Bands suggest that Intuitive Machines&#8217; stock is still in a bullish phase, riding the upper bullish band.
Intuitive Machines appears to be on a promising path with a NASA partnership and a solid technical setup.
As any seasoned investor knows, the sky's the limit, but it's wise to keep an eye on the stars—or, in this case, the charts.
Will Intuitive Machines&#8217; stock continue its ascent, or is it time to buckle in for a bumpy ride? Only time will tell.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com//node/40922597">Russell 2000 Outpaces S&amp;P 500 As Small Caps Anticipate Fed&#8217;s Interest Rate Move</a></li>
</ul>
Don't miss the opportunity to dominate in a volatile market at the&nbsp;<a href="https://www.benzinga.com/events/small-cap/global-small-cap-conference-2024/" target="_blank" rel="noreferrer noopener">Benzinga SmallCAP Conference on Oct. 9-10, 2024</a>,&nbsp;at the Chicago Marriott Downtown Magnificent Mile.
Get exclusive access to CEO presentations, 1:1 meetings with investors, and valuable insights from top financial experts. Whether you're a trader, entrepreneur, or investor, this event offers unparalleled opportunities to grow your portfolio and network with industry leaders.
<a href="https://www.benzinga.com/events/small-cap/global-small-cap-conference-2024/" target="_blank" rel="noreferrer noopener">Secure your spot and get your tickets today!</a>
Photo: Paitoon Pornsuksomboon/Shutterstock.com

SPACE

Technicals

Tech

LUNR

Intuitive Machines Rockets 240% Year-To-Date, Forms Golden Cross After $4.8B NASA Contract

As the <a href="https://www.benzinga.com/topic/2024-election">2024 elections</a> loom, presidential candidates are busy leveraging the popularity of cannabis reform. While former President <a href="https://www.benzinga.com/topic/donald-trump">Donald Trump</a> is using his newly found pro-cannabis stance to boost his popularity among Democrats and Independents, the Biden-Harris administration has taken a different approach.
On Friday, the White House revealed an <a href="https://www.whitehouse.gov/therecord/">updated webpage</a> highlighting accomplishments attributed to the administration. Among the new sections is one called "Issued a Review to Reschedule Marijuana," which features President <a href="https://www.benzinga.com/topic/joe-biden">Joe Biden</a>'s mass cannabis pardons, <a href="https://www.marijuanamoment.net/white-house-again-touts-biden-harris-marijuana-actions-but-with-less-lofty-rhetoric-in-light-of-rescheduling-delay/">reported</a> Marijuana Moment's Kyle Jaeger.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="970" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/24103819/ccc-oct-24-banner__1_-37.gif" alt="" class="wp-image-563420" /></a></figure>
The new language and reduced title of the section are more in line with skepticism among industry stakeholders and supporters than about any major actions on cannabis rescheduling before the election.
In August, the Drug Enforcement Administration (DEA) <a href="https://www.benzinga.com/markets/cannabis/24/08/40567326/dea-delays-cannabis-rescheduling-decision-until-after-november-presidential-election">announced a delay</a> in the rescheduling of marijuana noting it would hold an administrative hearing for December 2, pushing any decision on the matter until after the November elections. The section was previously titled "Ending our Failed Approach to Marijuana."
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40599655/cannabis-deregulation-before-the-election-cannabiz-supply-ceo-says-dont-count-on-it">Cannabis Deregulation Before The Election? Cannabiz Supply CEO Says, &#8216;Don&#8217;t Count On It&#8217;</a>
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
"To help remedy our country's failed approach to marijuana, including racial disparities, the Administration also launched the process to reclassify marijuana under federal law," the section reads. "Marijuana is currently a Schedule I drug, higher than the classification for fentanyl and methamphetamine—drugs driving our nation's overdose epidemic."
<h3 class="wp-block-heading">Biden's Mass Marijuana Pardons</h3>
Much like in its previous record page from 2022, the White House highlighted Biden's marijuana pardons.
However, as acknowledged by Biden himself, his <a href="https://www.benzinga.com/topic/cannabis-pardons">marijuana pardons</a> did not expunge records, despite previous claims. At a campaign event in Philadelphia earlier this year with VP <a href="https://www.benzinga.com/topic/kamala-harris">Kamala Harris</a>, Biden reiterated <a href="https://www.benzinga.com/markets/cannabis/24/03/37552483/biden-calls-for-cannabis-reform-in-state-of-the-union-a-historic-first-no-one-should-be-jailed-f">his commitment</a> to ensuring that no one should be in jail merely for <a href="https://www.benzinga.com/markets/cannabis/24/06/39317168/biden-admits-marijuana-pardons-did-not-expunge-records-not-a-good-look-for-dems-as-trump-moves-u">using or possessing marijuana.</a>  
Meanwhile, <a href="https://www.benzinga.com/general/politics/24/08/40536774/kamala-harris-accepts-historic-democratic-party-nomination-heres-what-comes-next-chance-to-chart">Democratic presidential candidate</a> Harris has been vociferous about her pro-legalization stance. Harris is the first presidential candidate from a major party to explicitly <a href="https://www.benzinga.com/topic/cannabis-reform">advocate for marijuana reform.</a> 
Pablo Zuanic, an equity analyst in the cannabis space said that Harris, if elected, could continue the Biden administration&#8217;s work on rescheduling but also take it a step further.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40913930/kamala-harris-moves-from-13-point-deficit-to-7-point-lead-over-trump-in-survey-of-fund-managers-stra">Kamala Harris Moves From 13-Point Deficit To 7-Point Lead Over Trump In Survey Of Fund Managers, Strategists And Economists</a></li>
</ul>

Cannabis

Government

Regulations

Politics

White House Highlights Marijuana Pardons Amid Skepticism Over Cannabis Rescheduling Efforts

U.S. FTC Says It Takes Action Against Invitation Homes For Deceiving Renters, Charging Junk Fees, Withholding Security Deposits, And Employing Unfair Eviction Practices

Jefferies analyst Joseph Gallo maintains CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) with a Buy and raises the price target from $315 to $345.

CRWD

Jefferies Maintains Buy on CrowdStrike Holdings, Raises Price Target to $345

Interactive Strength Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNR#NASDAQ">TRNR</a>) shares are trading higher on Tuesday after the company announced that CLMBR brand met EU-wide compliance requirements <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/ac40998667/interactive-strength-inc-nasdaq-trnr-successfully-passes-eu-compliance-for-clmbr-and-will-start-f" rel="noreferrer noopener">and obtained the required CE marking</a>.
The company will now begin fulfilling orders from exclusive distributors in Germany, Switzerland, and Austria.
The company&#8217;s Co-Founder and CEO Trent Ward stated that the third quarter results are expected to mark a significant shift in the company&#8217;s revenue growth, with higher expectations for the future as they access major fitness markets <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">outside the U.S. for the first time</a>.
Notably, during the second-quarter earnings call, the company provided third-quarter revenue <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/ac40403206/interactive-strength-inc-nasdaq-trnr-reports-second-quarter-2024-results" rel="noreferrer noopener">guidance of $2.0 million-$2.5 million</a>.
Trent Ward added, &#8220;We expect that distributors and key accounts from other countries will place orders now that we have received the CE marking since they will be able to import CLMBR into the EU.&#8221;
&#8220;We already have received a large order from our German distributor among others and we have a number of key commercial pilots in the United Kingdom, which could help us grow very quickly in the two largest fitness markets in Europe.&#8221;
This month, Interactive Strength disclosed that it secured exclusive distribution and an initial order for <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/ac40726284/interactive-strength-inc-nasdaq-trnr-secures-exclusive-distribution-for-clmbr-in-switzerland-and-" rel="noreferrer noopener">CLMBR in Switzerland and Austria</a>.
Also, CLMBR achieved Global Vendor Status with RSG Group, the owner of Gold&#8217;s Gym, McFit, John Reed, and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/ac40829216/interactive-strength-inc-nasdaq-trnr-secures-global-vendor-status-with-industry-leader-rsg-group-" rel="noreferrer noopener">other brands with over 900 locations</a>.
Price Action: TRNR shares are up 10.4% at $0.2610 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41005694" target="_blank" rel="noreferrer noopener">Bitcoin Is &#8216;Gold With A Leverage,&#8217; Says Expert Who Sees US Government In Big Trouble Over Debt Burden</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Guidance

Small Cap

Movers

TRNR

Why Is Interactive Strength Stock Surging Today?

Events

UPDATE: Watching Global Payments; Shares See Sharp Volume Spike To The Downside, Co Currently Hosting Its 2024 Investor Conference

Jefferies analyst Joseph Gallo maintains Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Buy and raises the price target from $210 to $225.

CHKP

Jefferies Maintains Buy on Check Point Software, Raises Price Target to $225

Whales with a lot of money to spend have taken a noticeably bearish stance on Affirm Holdings.
Looking at options history for Affirm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 15% of the investors opened trades with bullish expectations and 84% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $219,952 and 10, calls, for a total amount of $1,082,873.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $60.0 for Affirm Holdings over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Affirm Holdings's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Affirm Holdings's whale activity within a strike price range from $10.0 to $60.0 in the last 30 days. 
<h3>Affirm Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727191857_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$12.9</td>
<td>$12.75</td>
<td>$12.75</td>
<td>$35.00</td>
<td>$382.5K</td>
<td>1.2K</td>
<td>501</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$13.1</td>
<td>$12.95</td>
<td>$12.95</td>
<td>$35.00</td>
<td>$259.0K</td>
<td>1.2K</td>
<td>201</td>
</tr>
<tr>
<td>AFRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$34.95</td>
<td>$33.45</td>
<td>$33.75</td>
<td>$10.00</td>
<td>$108.0K</td>
<td>502</td>
<td>32</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/27/24</td>
<td>$2.67</td>
<td>$2.39</td>
<td>$2.5</td>
<td>$46.50</td>
<td>$99.5K</td>
<td>500</td>
<td>400</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$0.68</td>
<td>$0.64</td>
<td>$0.68</td>
<td>$37.50</td>
<td>$93.7K</td>
<td>3.5K</td>
<td>1.3K</td>
</tr>
</tbody>
</table>

<h3>About Affirm Holdings</h3>
Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.
<h3>Affirm Holdings's Current Market Status</h3>
<ul>
<li>With a volume of 3,727,737, the price of AFRM is down -4.01% at $42.88. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 43 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Affirm Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

AFRM

Market Whales and Their Recent Bets on AFRM Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) we detected 11 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 36% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $106,450 and 8, calls, for a total amount of $407,096.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $90.0 to $150.0 for Novo Nordisk during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Novo Nordisk stands at 634.4, with a total volume reaching 361.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Novo Nordisk, situated within the strike price corridor from $90.0 to $150.0, throughout the last 30 days.
<h3>Novo Nordisk 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727191852_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$17.75</td>
<td>$17.4</td>
<td>$17.56</td>
<td>$120.00</td>
<td>$105.3K</td>
<td>22</td>
<td style="text-align: right;">60</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/20/24</td>
<td>$7.1</td>
<td>$6.95</td>
<td>$7.03</td>
<td>$130.00</td>
<td>$67.2K</td>
<td>1.9K</td>
<td style="text-align: right;">109</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$25.65</td>
<td>$25.25</td>
<td>$25.25</td>
<td>$150.00</td>
<td>$50.5K</td>
<td>82</td>
<td style="text-align: right;">20</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$9.8</td>
<td>$9.75</td>
<td>$9.8</td>
<td>$125.00</td>
<td>$49.0K</td>
<td>404</td>
<td style="text-align: right;">65</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$10.6</td>
<td>$10.4</td>
<td>$10.5</td>
<td>$125.00</td>
<td>$47.2K</td>
<td>1.2K</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
In light of the recent options history for Novo Nordisk, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Novo Nordisk</h3>
<ul>
<li>Trading volume stands at 1,723,363, with NVO's price up by 1.47%, positioned at $125.52.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 43 days.</li>
</ul>
<h3>What The Experts Say On Novo Nordisk</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $160.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $160. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $160. 
&#x2A; An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Novo Nordisk's Options: A Look at What the Big Money is Thinking

Investors with a lot of money to spend have taken a bearish stance on Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with UPST, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 12 uncommon options trades for Upstart Hldgs.
This isn't normal.
The overall sentiment of these big-money traders is split between 41% bullish and 50%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $148,137, and 9 are calls, for a total amount of $668,977.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $55.0 for Upstart Hldgs over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Upstart Hldgs stands at 1385.0, with a total volume reaching 5,082.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Upstart Hldgs, situated within the strike price corridor from $15.0 to $55.0, throughout the last 30 days.
<h3>Upstart Hldgs Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727191846_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/04/24</td>
<td>$1.04</td>
<td>$1.01</td>
<td>$1.01</td>
<td>$39.00</td>
<td>$316.7K</td>
<td>144</td>
<td>3.1K</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$8.05</td>
<td>$7.85</td>
<td>$7.85</td>
<td>$42.50</td>
<td>$66.7K</td>
<td>235</td>
<td>100</td>
</tr>
<tr>
<td>UPST</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.15</td>
<td>$6.0</td>
<td>$6.05</td>
<td>$37.50</td>
<td>$60.5K</td>
<td>1.7K</td>
<td>100</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$11.55</td>
<td>$11.45</td>
<td>$11.55</td>
<td>$35.00</td>
<td>$57.7K</td>
<td>461</td>
<td>74</td>
</tr>
<tr>
<td>UPST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$12.85</td>
<td>$11.8</td>
<td>$12.85</td>
<td>$55.00</td>
<td>$55.2K</td>
<td>92</td>
<td>43</td>
</tr>
</tbody>
</table>

<h3>About Upstart Hldgs</h3>
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit and small dollar loans.
Following our analysis of the options activities associated with Upstart Hldgs, we pivot to a closer look at the company's own performance.
<h3>Current Position of Upstart Hldgs</h3>
<ul>
<li>With a trading volume of 2,770,127, the price of UPST is down by -4.41%, reaching $36.83.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 42 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Upstart Hldgs</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $48.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Upstart Hldgs with a target price of $48. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Upstart Hldgs with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

UPST

Check Out What Whales Are Doing With UPST

Tenet Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) has outperformed the market over the past 15 years by 1.98% on an annualized basis producing an average annual return of 13.87%. Currently, Tenet Healthcare has a market capitalization of $16.08 billion. 
Buying $100 In THC: If an investor had bought $100 of THC stock 15 years ago, it would be worth $712.82 today based on a price of $167.85 for THC at the time of writing.
<h3>Tenet Healthcare's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727191821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Tenet Healthcare 15 Years Ago Would Be Worth This Much Today

Curreen Capital Q4 2023 Investor Letter

Advantage Solutions Inc. 2023 Q4 - Results - Earnings Call Presentation

Advantage Solutions Inc. (ADV) Q4 2023 Earnings Call Transcript

Advantage Solutions Inc. (ADV) Q1 2024 Earnings Call Transcript

Advantage Solutions Inc. 2024 Q1 - Results - Earnings Call Presentation

Curreen Capital Q2 2024 Investor Letter

Curreen Capital's Top 5% Positions: Where I Am Finding The Most Value

Advantage Solutions Inc. (ADV) Q2 2024 Earnings Call Transcript

Advantage Solutions Inc. 2024 Q2 - Results - Earnings Call Presentation

ADVWW

CACC

DYNDF

EHAB

FTDR

GETBF

SOLV

Advantage Solutions Inc. - Class A Common Stock

Advantage Solutions

Boston Omaha Corporation Class A Common Stock

Boston Omaha

Clear Channel Outdoor Holdings, Inc. Common Stock

Clear Channel Outdoor

Cardlytics

Criteo

Innovid

Emerald Holding

Entravision Communications Corporation Common Stock

Entravision Comms

Gambling.com Group Limited - Ordinary Shares

Gambling.com Gr

Integral Ad Science Holding Corp. - Common Stock

Integral Ad Science

Ibotta

Interpublic Group of Companies, Inc. (The) Common Stock

Interpublic Gr of Cos

Marchex

Magnite

National CineMedia

Nexxen International Ltd. - American Depository Shares

Nexxen International

Omnicom Group

PubMatic

QMMM Holdings

Starbox Group Holdings Ltd. - Class A Ordinary Shares

Starbox Group Hldgs

Stagwell

Thryv Holdings

The Trade Desk, Inc. - Class A Common Stock

Trade Desk

TechTarget

WiMi Hologram Cloud Inc. - American Depositary Share

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Advantage Solutions

News

Latest news for Advantage Solutions (NASDAQ:ADVWW) Stock

People Also Watch